Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and endothelial dysfunction in active rheumatoid arthritis
NL-OMON21369Recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Open-label, single-arm trial of rituximab in rheumatoid arthritis (RA), sponsored by University Medical Center Groningen. Primary endpoint: Change in endothelial dysfunction measured by pulse wave analysis. Started May 2011; status: recruiting.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NL-OMON21369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21369.